GGrantIndex
Sort

46,585 grants matching heart failure

Development of inhibitors and diagnostics for amyloid diseases

$1,950,000
David Eisenberg · University Of California Los Angeles · RF1 · FY2019 · AG

Myocardial Hypertrophy and Heart Failure

$1,949,141
Stephen F Vatner · Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2006 · HL

CORAL: Clinical Coordinating Center

$1,948,320
Christopher J Cooper · University Of Toledo Health Sci Campus · U01 · FY2007 · HL

Development and Clinical Testing of CorAide RVAD/BVAD

$1,947,997
Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2005 · HL

Warfarin vs Aspirin in Reduced Ejection Fraction-CLIN

$1,946,580
Shunichi Homma · Columbia University Health Sciences · U01 · FY2007 · NS

Magscrew TAH Testing thru Pre-Clinical Readiness

$1,946,424
Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2003 · HL

Neurohumoral adaptations to chronic intermittent hypoxia

$1,945,334
Steven W. Mifflin · University Of Texas Hlth Science Center · P01 · FY2008 · HL

Nonmyeloablative allogeneic PBSC in globin disorders

$1,943,482
John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Multiethnic Study of Breast Arterial Calcium Gradation and CVD

$1,941,361
Carlos Iribarren · Kaiser Foundation Research Institute · R01 · FY2011 · HL

Integrated Mechanisms of Cardiac Maladaptation

$1,941,121
R John Solaro · University Of Illinois At Chicago · P01 · FY2016 · HL

Cardiac Myosin Binding Protein-C: Structure, Function, and Regulation

$1,940,586
David M Warshaw · University Of Vermont & St Agric College · P01 · FY2013 · HL

GENERAL CLINICAL RESEARCH CENTER

$1,940,372
University Of Colorado Denver · M01 · FY2002 · RR

CONSTRUCTION OF A GENETIC LINKAGE MAP OF ZEBRAFISH

$1,939,699
Massachusetts General Hospital · R01 · FY2000 · DK

Gene Therapy for Lung and Cardiovascular Disease

$1,936,840
University Of Florida · P01 · FY2003 · HL

CLINICAL EXAMINATION CENTER

$1,932,883
Josef Coresh · Johns Hopkins University · N01 · FY2014 · HL

Role of O-glycosylation in Animal Development

$1,932,724
Kelly G Ten Hagen · National Institute Of Dental & Craniofacial Research · ZIA · FY2020 · DE

Pharmacogenomic Evaluation of Antihypertensive Responses

$1,932,019
Julie A. Johnson · University Of Florida · U01 · FY2012 · GM

Mechanisms of cardiac ischemia-reperfusion injury and cardioprotection

$1,931,840
Elizabeth Murphy · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL

DNA virus as vectors for cardiovascular diseases

$1,929,679
James M Wilson · University Of Pennsylvania · P01 · FY2008 · HL

Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD

$1,928,443
Rima F Kaddurah-Daouk · Duke University · U01 · FY2022 · AG

Genome-wide study of sudden cardiac arrest in the community

$1,928,268
David Siscovick · University Of Washington · R01 · FY2009 · HL

Long-acting PTH for hypoparathyroidism

$1,928,001
Laura M Hales · Extend Biosciences, Inc. · R44 · FY2018 · DK

SPECIALIZED CENTER OF RESEARCH IN SUDDEN CARDIAC DEATH

$1,927,484
Johns Hopkins University · P50 · FY2001 · HL

REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-4 (REGARDS-MI-4)

$1,926,124
Monika M Safford · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · HL

Stem Cell and Cardiac Aging

$1,925,490
New York Medical College · P01 · FY2005 · AG